- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04563663
Dose-response of Anteroposterior Mobilizations in Weight Bearing Talus Dorsiflexion (ANKLE_WBROM)
April 27, 2021 updated by: David Hernández, University of Valencia
Dose-response of Anteroposterior Mobilizations in Weight Bearing Talus Dorsiflexion in the Older Adult: Allegorized Clinical Trial
Ankle mobility limitations are common in older adults.
A possible treatment to restore joint mobility is manual therapy based on mobilization techniques, in this case, applied on the ankle joint.
Previous research had proposed different treatment volumes (one to twelve sessions), but shown a different and non-consistent degree of effectiveness according to such factor.
Therefore, this work aims to determine the dose-response relationship of manual therapy (talus mobilizations) on ankle range of motion in the older adult.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Valencia, Spain, 46010
- Universidad de Valencia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Community-dwelling older adults.
- Limited ankle mobility (< 35 degrees).
- Over 60 years.
Exclusion Criteria:
- Not willing to participate or signing a consent form
- Lower limb injury in the three months prior to the study (ex. sprain)
- Diagnosed condition that may influence mobility assessments (i.e. stroke)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: One session
One session of talus posteriorization.
|
Three sets of a 30-s grade IV anteroposterior mobilization.
|
|
Experimental: Two sessions
Two sessions of talus posteriorization.
|
Three sets of a 30-s grade IV anteroposterior mobilization.
|
|
Experimental: Three sessions
Three sessions of talus posteriorization.
|
Three sets of a 30-s grade IV anteroposterior mobilization.
|
|
Experimental: Four sessions
Four sessions of talus posteriorization.
|
Three sets of a 30-s grade IV anteroposterior mobilization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment dose
Time Frame: Change from baseline to end of intervention (2 weeks) and follow-up (10 weeks)
|
Number of sessions of experimental intervention needed to induce a clinically important gain in ankle mobility after the intervention.
A baseline progression over 4.6º in the Lunge test will be considered clinically important (Powden, 2015), so that the number of sessions will be established when this threshold is exceeded (see secondary outcome) .
|
Change from baseline to end of intervention (2 weeks) and follow-up (10 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Lunge test
Time Frame: Change from baseline, to end of intervention (2 weeks) and follow-up (10 weeks)
|
Weight bearing ankle dorsiflexion range of motion.
This test will measure the maximum tilt of the tibia that a subject can perform while standing and bearing the weight on the limb without lifting the heel from the floor.
A Baseline® Digital Inclinometer (Fabrication Enterprises Inc) will be used to assessed this outcome.
Values below 35º indicate limited mobility.
A baseline progression over 4.6º will be considered clinically important (Powden, 2015).
This mobility gain will be used to determine the dose-response relationship: number of sessions of talus mobilizations needed to induce a clinically important gain in ankle mobility after the intervention (see primary outcome measure)
|
Change from baseline, to end of intervention (2 weeks) and follow-up (10 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: José-María Blasco, University of Valencia
- Principal Investigator: David Hernández-Guillén, University of Valencia
- Study Chair: Catalina Tolsada-Velasco, University of Valencia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Actual)
October 16, 2020
Study Completion (Actual)
December 16, 2020
Study Registration Dates
First Submitted
September 18, 2020
First Submitted That Met QC Criteria
September 18, 2020
First Posted (Actual)
September 24, 2020
Study Record Updates
Last Update Posted (Actual)
April 28, 2021
Last Update Submitted That Met QC Criteria
April 27, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- KTV01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging Problems
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
University of Santiago de CompostelaState Research Agency, SpainCompleted
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Seoul National University Bundang HospitalCompleted
-
University of MichiganTerminated
-
University of ValenciaCompletedAging ProblemsSpain
-
University of ValenciaCompletedAging ProblemsSpain
-
University of ValenciaUnknownAging ProblemsSpain
-
University of ValenciaTerminated
Clinical Trials on Posteriorization of the talus.
-
University of ValenciaTerminated
-
Stefano ZaffagniniActive, not recruitingOsteochondral DefectItaly
-
Gazi UniversityEnrolling by invitationGait Analysis | Microfracture Procedure | Osteochondral Defects of Talus | Biological ScaffoldTurkey (Türkiye)
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Clinique BizetCompletedElectromagnetic Emissions and Emotional Disorder | Electromagnetic Emissions and Medication SavingsFrance
-
University of ZurichTerminatedLung Disease | Wrist FractureSwitzerland
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Hospices Civils de LyonRecruiting
-
VA Greater Los Angeles Healthcare SystemRecruitingPosttraumatic Stress DisorderUnited States